DE69225791D1 - Monoklonale Antikörper gegen Tetanustoxin und sie enthaltende pharmazeutische Zusammensetzungen - Google Patents

Monoklonale Antikörper gegen Tetanustoxin und sie enthaltende pharmazeutische Zusammensetzungen

Info

Publication number
DE69225791D1
DE69225791D1 DE69225791T DE69225791T DE69225791D1 DE 69225791 D1 DE69225791 D1 DE 69225791D1 DE 69225791 T DE69225791 T DE 69225791T DE 69225791 T DE69225791 T DE 69225791T DE 69225791 D1 DE69225791 D1 DE 69225791D1
Authority
DE
Germany
Prior art keywords
tetanus toxin
pharmaceutical compositions
tetanus
monoclonal antibodies
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69225791T
Other languages
English (en)
Other versions
DE69225791T2 (de
Inventor
Alois B Dr Lang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cilag GmbH International
Original Assignee
Schweiz Serum und Impfinstitut Bern
Schweiz Serum und Impfinstitut und Institut zur Erforschung der Infektionskrankheiten
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schweiz Serum und Impfinstitut Bern, Schweiz Serum und Impfinstitut und Institut zur Erforschung der Infektionskrankheiten filed Critical Schweiz Serum und Impfinstitut Bern
Publication of DE69225791D1 publication Critical patent/DE69225791D1/de
Application granted granted Critical
Publication of DE69225791T2 publication Critical patent/DE69225791T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1282—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Clostridium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69225791T 1992-03-23 1992-03-23 Monoklonale Antikörper gegen Tetanustoxin und sie enthaltende pharmazeutische Zusammensetzungen Expired - Fee Related DE69225791T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92105000A EP0562132B1 (de) 1992-03-23 1992-03-23 Monoklonale Antikörper gegen Tetanustoxin und sie enthaltende pharmazeutische Zusammensetzungen

Publications (2)

Publication Number Publication Date
DE69225791D1 true DE69225791D1 (de) 1998-07-09
DE69225791T2 DE69225791T2 (de) 1998-10-22

Family

ID=8209459

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69225791T Expired - Fee Related DE69225791T2 (de) 1992-03-23 1992-03-23 Monoklonale Antikörper gegen Tetanustoxin und sie enthaltende pharmazeutische Zusammensetzungen

Country Status (5)

Country Link
EP (1) EP0562132B1 (de)
AT (1) ATE166924T1 (de)
DE (1) DE69225791T2 (de)
DK (1) DK0562132T3 (de)
ES (1) ES2119785T3 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6287566B1 (en) * 1995-05-19 2001-09-11 The United States Of America As Represented By The Secretary Of The Army Protective peptides neurotoxin of C. botulinum
CN101220096B (zh) * 2003-12-30 2010-09-29 龚小迪 人源抗破伤风毒素单克隆抗体的制备和应用
CN1305904C (zh) * 2003-12-30 2007-03-21 龚小迪 人源的抗破伤风毒素单克隆抗体的制备和应用
FR2962439A1 (fr) 2010-07-12 2012-01-13 Lfb Biotechnologies Anticorps monoclonaux diriges contre la toxine tetanique
EP3514175A1 (de) 2012-12-17 2019-07-24 Laboratoire Français du Fractionnement et des Biotechnologies Einsatz von monoklonalen antikörpern für die behandlung von bakteriellen entzündungen und infektionen
BR102016017782A2 (pt) 2016-07-29 2018-02-14 Fundação Butantan Anticorpos monoclonais humanos antitetânicos neutralizantes para a infecção por c.tetani, método de obtenção dos ditos anticorpos monoclonais e seu uso na imunoterapia para acidentes susceptíveis à infecção pelo bacilo tetânico
WO2018078643A1 (en) 2016-10-26 2018-05-03 Bharat Serums And Vaccines Ltd. Monoclonal antibodies neutralizing the tetanus toxin
CN108314731B (zh) * 2017-12-29 2019-02-12 珠海泰诺麦博生物技术有限公司 一种针对破伤风毒素的全人源单克隆中和抗体及其应用
CN108314730B (zh) * 2017-12-29 2019-01-08 珠海泰诺麦博生物技术有限公司 抗破伤风毒素中和抗体及其制备与应用
CN108218984B (zh) * 2017-12-29 2018-10-26 珠海泰诺麦博生物技术有限公司 一种抗破伤风毒素的全人源中和抗体
EP3733699A4 (de) * 2017-12-29 2022-06-08 Zhuhai Trinomab Biotechnology Co., Ltd. Vollständig humanisierter monoklonaler neutralisierender antikörper für tetanustoxin und dessen verwendung

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60203186A (ja) * 1984-03-28 1985-10-14 Green Cross Corp:The ヒト−ヒトハイブリド−マ

Also Published As

Publication number Publication date
EP0562132A1 (de) 1993-09-29
EP0562132B1 (de) 1998-06-03
ATE166924T1 (de) 1998-06-15
DK0562132T3 (da) 1999-03-22
ES2119785T3 (es) 1998-10-16
DE69225791T2 (de) 1998-10-22

Similar Documents

Publication Publication Date Title
DE69225791D1 (de) Monoklonale Antikörper gegen Tetanustoxin und sie enthaltende pharmazeutische Zusammensetzungen
LU93274I2 (fr) Elotuzumab
IL90990A0 (en) Pharmaceutical and diagnostic compositions containing monoclonal antibodies reactive with cachectin and a cell for the production thereof
MX9206540A (es) Genes para la beta-cetoacil-acp sintetasa ii de; plantas.
DE69724428D1 (de) Humanisierte antikörper die an das gleiche antigen wie antikörper nr-lu-13 binden und deren verwendung in "pretargeting" verfahren
AR035977A1 (es) Inmunoconjugados de anticuerpos cd44 citotoxicos.
ES2127531T3 (es) Medicamento para la inmunosupresion prolongada y la eliminacion de celulas tumorales.
DE69504959T2 (de) Humanisierte monoklonale antikörper gegen humanes interleukin - 4
ES1022524Y (es) Dispositivo para injertar plantas de vivero.
DE69806465T2 (de) Eine heteroethynylen-brücke enthaltende bi-aromatische verbindungen und diese enthaltende pharmazeutische und kosmetische zusammensetzungen
EP0619324A4 (en) Human type antibody reactive with gpiib/iiia.
DE3887417D1 (de) Thienocinnolinverbindungen und deren verwendung als heilmittel.
ATE236120T1 (de) Sulfonamid-substituierte anellierte 5-ring- verbindungen, ihre verwendung als medikament sowie sie enthaltende pharmazeutische zubereitungen
DE3888604T2 (de) Monoklonale Antikörper gegen Antithrombinbindende Substanz und seine Verwendungen.
DE68927340T2 (de) Biologischer impfstoff, wirksam gegen aphanomyces
DE69213423D1 (de) Germaniumverbindungen und deren Verwendung als bioverträgliche Oel
DE59207362D1 (de) Monoklonale Antikörper gegen den Plasmin-Antiplasmin Komplex, Verfahren zu ihrer Herstellung sowie ihre Verwendung
DE69012034T2 (de) Monoklonaler Antikörper gegen Exotoxin A von Pseudomonas aeruginosa.
DE69407905T2 (de) Rauchgasentschwefelung mit biologischer Regenerierung
NO972348D0 (no) Behandlingsanlegg for bioavfall
FR2694375B1 (fr) Four d'Incinération Polyvalent.
ITMI910660A0 (it) Anticorpi monoclonali come antidoti
KR930017483U (ko) 식물 재배용 주사기
ES1025358Y (es) Contenedor de enraizamiento de plantas.
ES1027495Y (es) Contendor de enraizamiento y desarrollo de plantas.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee